Prescription pricing -- United States
Resource Information
The concept Prescription pricing -- United States represents the subject, aboutness, idea or notion of resources found in Jacksonville Public Library.
The Resource
Prescription pricing -- United States
Resource Information
The concept Prescription pricing -- United States represents the subject, aboutness, idea or notion of resources found in Jacksonville Public Library.
- Label
- Prescription pricing -- United States
86 Items that share the Concept Prescription pricing -- United States
Context
Context of Prescription pricing -- United StatesSubject of
No resources found
No enriched resources found
- Would prescription drug importation reduce U.S. drug spending?
- 4 ways to help lower your Medicare prescription drug costs
- A detailed description of CBO's cost estimate for the Medicare prescription drug benefit
- A prescription for savings : reducing drug costs to Medicare : hearing before the Special Committee on Aging, United States Senate, One Hundred Twelfth Congress, first session, Washington, DC, July 21, 2011
- Changes in co-pays employer-sponsored health insurance plans, 1999-2003
- Comparison of reimbursement prices for multiple-source prescription drugs in the United States and Canada
- Competition and the cost of Medicare's prescription drug program
- DOD and VA pharmacy : progress and remaining challenges in jointly buying and mailing out drugs : report to Congressional requesters
- Description of subtitle J - drug pricing : budget reconciliation legislative recommendations : scheduled for markup by the House Committee on Ways and Means on September 14, 2021
- Developments in the prescription drug market : oversight : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fourteenth Congress, second session, February 4, 2016
- Direct-to-consumer advertising : marketing, education, or deception? : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, May 8, 2008
- Drug prices : the role of patents and regulatory exclusivities
- Drug pricing : manufacturer discounts in the 340B program offer benefits, but federal oversight needs improvement : report to congressional committees
- Drug pricing and intellectual property : the legislative landscape for the 117th Congress
- Drug pricing in America : a prescription for change : hearing before the Committee on Finance, United States Senate, One Hundred Sixteenth Congress, first session
- Drug pricing in America : a prescription for change : hearing before the Committee on Finance, United States Senate, One Hundred Sixteenth Congress, first session
- Drug shortages : causes, FDA authority, and policy options
- Effects of medicare's drug pricing on other purchasers
- Effects of using generic drugs on Medicare's prescription drug spending
- EpiPen price increases : how regulatory barriers inhibit pharmaceutical competition : field hearing of the Subcommittee on Children and Families of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session on examining EpiPen price increases, focusing on how regulatory barriers inhibit pharmaceutical competition, October 7, 2016 (Lexington, KY)
- Estimated budgetary effects of an amendment in the nature of s substitute to the revenue provisions of subtitles F, G, H, I, and J of the budget reconciliation legislative recommendations relating to infrastructure financing and community development, green energy, social safety net, responsibly funding our priorities, and drug pricing scheduled for markup by the Committee On Ways And Means on September 14, 2021
- Estimated budgetary effects of the revenue provisions of subtitles F, G, H, and J of the budget reconciliation legislative recommendations relating to infrastructure financing, green energy, social safety net, and drug pricing
- Examining prescription drug importation : a review of a proposal to allow third parties to reimport prescription drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, July 25, 2002
- Examining the drug supply chain : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, December 13, 2017
- Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain : hearing before the Subcommittee on Healthcare, Benefits, and Administrative Rules of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017
- Family health care expenses, by size of family, 2002
- Frequently asked questions about prescription drug pricing and policy
- Generic drug user fee amendments : accelerating patient access to generic drugs : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session ... January 28, 2016
- Implementation of the Medicare drug benefit : hearing before the Subcommittee on Health of the Committee on Ways and Means, U.S. House of Representatives, One Hundred Ninth Congress, second session,May 3 and May 4, 2006
- Improving drug pricing transparency and lowering prices for American consumers : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, May 21, 2019
- Las apariencias engañan : la medicina que usted compra fuera de los Estados Unidos puede ser peligrosa y deficiente
- Looks can be deceiving : the medicine you buy from outside the United States may be unsafe or ineffective
- Making health care more affordable : lowering drug prices and increasing transparency : hearing before the Subcommittee on Health, Employment, Labor and Pensions, Committee on Education and Labor, U.S. House of Representatives, One Hundred Sixteenth Congress, first session : hearing held in Washington, DC, September 26, 2019
- Manufactured crisis : how better negotiation could save billions for Medicare and America's seniors
- Manufactured crisis : how devastating drug price increases are harming America's seniors
- Medicaid prescription drugs : CMS should implement revised federal upper limits and monitor their relationship to retail pharmacy acquisition costs : report to congressional requesters
- Medicare payments for currently covered prescription drugs : hearing before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, One Hundred Seventh Congress, second session, October 3, 2002
- Medicare prescription drug benefit : review and oversight : hearing before the Committee on Finance, United States Senate, One Hundred Tenth Congress, first session, May 8, 2007
- Options for safe and effective prescription drug importation : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Eighth Congress, second session, March 11, 2004
- Out-of-pocket cost and acquisition of prescribed medicines, United States, 1973
- Out-of-pocket health care expenses by age and insurance coverage, 2003
- Outpatient prescribed medicine expenses by source of payment and insurance status for the Medicare and non-Medicare populations, 2003
- Outpatient prescribed medicines : a comparison of use and expenditures, 1987 and 2001
- Outpatient prescription medicines : a comparison of expenditures by household-reported condition, 1987 and 2001
- Pay-for-delay : how drug company pay-offs cost consumers billions : an FTC staff study
- Pay-for-delay deals : limiting competition and costing consumers : hearing before the Subcommittee on Antitrust, Competition Policy and Consumer Rights of the Committee on the Judiciary, United States Senate, One Hundred Thirteenth Congress, first session, July 23, 2013
- Persistence in Medicare prescription drug expenditures by treatment class
- Policy implications of pharmaceutical importation for U.S. consumers : hearing before the Subcommittee on Interstate Commerce, Trade, and Tourism of the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Tenth Congress, first session, March 7, 2007
- Potential effects of a ban on direct-to-consumer advertising of new prescription drugs
- Prescription Drug Sunshine, Transparency, Accountability and Reporting Act : report (to accompany H.R. 2113) (including cost estimate of the Congressional Budget Office)
- Prescription drug affordability and innovation : addressing challenges in today's market : hearing before the Committee on Finance, United States Senate, One Hundred Fifteenth Congress, second session, June 26, 2018
- Prescription drug benefits: impact of Medicare HMO's use of formularies on beneficiaries : testimony before the Special Committee on Aging, U.S. Senate
- Prescription drug discount coupons and patient assistance programs (PAPs)
- Prescription drug importation
- Prescription drug price inflation : are prices rising too fast? : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, first session, December 8, 2009
- Prescription drug pricing and negotiation : overview and economic perspectives for the Medicare prescription drug benefit : hearing before the Committee on Finance, United States Senate, One Hundred Tenth Congress, first session, January 11, 2007
- Prescription drug reimportation : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Eighth Congress, first session, November 20, 2003
- Prescription drugs : out-of-pocket expenses and unmet need relative to family income, 2002
- Prescription drugs : prices available through discount cards and from other sources
- Prices for brand-name drugs under selected federal programs
- Replacing average wholesale price : Medicaid drug payment policy
- Report on prescription drug importation
- Small market drugs, big price tags : are drug companies exploiting people with rare disease? : hearing before the Joint Economic Committee, Congress of the United States, One Hundred Tenth Congress, second session, July 24, 2008
- Special report of the U.S. Senate Special Committee on Aging on the sudden price spikes in off-patent prescription drugs : the monopoly business model that harms patients, taxpayers, and the U.S. health system
- States' collection of offset and supplemental Medicaid rebates
- Strategies used by adults to reduce their prescription drug costs
- Strategies used by adults to reduce their prescription drug costs : United States, 2013
- Tax provisions in the "Build Back Better Act" : the House Ways and Means Committee's legislative recommendations
- Ten years later : a look at the Medicare prescription drug program : hearing before the Special Committee on Aging, United States Senate, One Hundred Thirteenth Congress, first session : Washington, DC, Wednesday, May 22, 2013
- The Medicare drug benefit : are private insurers getting good discounts for the taxpayer? : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, second session, July 24, 2008
- The Prescription Drug Pricing Reduction Act of 2019 : report (to accompany 2543)
- The big fix : how the pharmaceutical industry rips off American consumers
- The cost of prescription drugs : examining the President's blueprint 'American Patients First' to lower drug prices : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, second session, on examining the cost of prescription drugs, focusing on examining the President's blueprint 'American Patients First' to lower drug prices, June 12, 2018
- The insular areas Medicaid cliff : oversight hearing before the Committee on Natural Resources, U.S. House of Representatives, One Hundred Sixteenth Congress, first session, Thursday, May 23, 2019
- The other drug war
- The top five outpatient prescription drugs ranked by total expense for Medicare beneficiaries, by insurance status, 2004
- The top five outpatient prescription drugs ranked by total expense for children, adults, and the elderly, 2004
- The truth about the drug companies : how they deceive us and what to do about it
- The truth about the drug companies : how they deceive us and what to do about it
- Top 10 outpatient prescription medicines ranked by utilization and expenditures for the U.S. community population, 2002
- Top 10 outpatient prescription medicines ranked by utilization and expenditures for the near elderly in the U.S. community population, 2002
- Treating the opioid epidemic : the state of competition in the markets for addiction medication : hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fourteenth Congress, second session, September 22, 2016
- Trends in national health care expenses in the U.S. civilian noninstitutionalized population, 1997 versus 2002
- Trends in statins utilization and expenditures for the U.S. civilian noninstitutionalized population, 2000 and 2005
- Unsustainable drug prices : hearing before the Committee on Oversight and Reform, House of Representatives
- Why are some generic drugs skyrocketing in price? : hearing before the Subcommittee on Primary Health and Aging of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Thirteenth Congress, second session, on examining the pricing of generic drugs, November 20, 2014
Embed
Settings
Select options that apply then copy and paste the RDF/HTML data fragment to include in your application
Embed this data in a secure (HTTPS) page:
Layout options:
Include data citation:
<div class="citation" vocab="http://schema.org/"><i class="fa fa-external-link-square fa-fw"></i> Data from <span resource="http://link.jaxpubliclibrary.org/resource/W8Kd_30OL94/" typeof="CategoryCode http://bibfra.me/vocab/lite/Concept"><span property="name http://bibfra.me/vocab/lite/label"><a href="http://link.jaxpubliclibrary.org/resource/W8Kd_30OL94/">Prescription pricing -- United States</a></span> - <span property="potentialAction" typeOf="OrganizeAction"><span property="agent" typeof="LibrarySystem http://library.link/vocab/LibrarySystem" resource="http://link.jaxpubliclibrary.org/"><span property="name http://bibfra.me/vocab/lite/label"><a property="url" href="http://link.jaxpubliclibrary.org/">Jacksonville Public Library</a></span></span></span></span></div>
Note: Adjust the width and height settings defined in the RDF/HTML code fragment to best match your requirements
Preview
Cite Data - Experimental
Data Citation of the Concept Prescription pricing -- United States
Copy and paste the following RDF/HTML data fragment to cite this resource
<div class="citation" vocab="http://schema.org/"><i class="fa fa-external-link-square fa-fw"></i> Data from <span resource="http://link.jaxpubliclibrary.org/resource/W8Kd_30OL94/" typeof="CategoryCode http://bibfra.me/vocab/lite/Concept"><span property="name http://bibfra.me/vocab/lite/label"><a href="http://link.jaxpubliclibrary.org/resource/W8Kd_30OL94/">Prescription pricing -- United States</a></span> - <span property="potentialAction" typeOf="OrganizeAction"><span property="agent" typeof="LibrarySystem http://library.link/vocab/LibrarySystem" resource="http://link.jaxpubliclibrary.org/"><span property="name http://bibfra.me/vocab/lite/label"><a property="url" href="http://link.jaxpubliclibrary.org/">Jacksonville Public Library</a></span></span></span></span></div>
